Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer

@article{Nakagoe2002ExpressionOA,
  title={Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer},
  author={Tohru Nakagoe and Kiyoyasu Fukushima and Noriaki Itoyanagi and Yasushi Ikuta and Tadayuki Oka and Takeshi Nagayasu and Hiroyoshi Ayabe and S Hara and Hiroshi Ishikawa and Hiroyuki Minami},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2002},
  volume={128},
  pages={257-264}
}
Abstract.Purpose: The prognostic value of altered blood group factor and Lewis-related carbohydrate antigen expression in breast cancers has not been fully determined. Methods: To this end, breast carcinoma samples from 87 radical mastectomy patients with primary cancer were analyzed by immunohistochemistry for the ABH factors, Lea, sialyl Lea, Lex, and sialyl Lex. Results: It was found that ABH, Lea, sialyl Lea, Lex, and sialyl Lex antigens were expressed in 25 (21.8%), 26 (22.6%), 26 (22.6… 
Is Sialyl Lewis x Antigen Expression a Prognostic Factor in Patients With Breast Cancer?
TLDR
Investigation of the prognostic value of sLex in a series of breast carcinomas with long-term follow-up found that expression of s Lex antigen in breast cancer is not associated with breast cancer survival.
Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue.
TLDR
Increased expressions of sialyl Lewisa antigen in serum and sialy Lewisx antigen in tumor tissue may be associated with poor prognosis in colorectal cancer patients.
Expression of Lewis X is associated with poor prognosis in triple-negative breast cancer.
TLDR
The results suggest that Le(X) expression is an independent prognostic factor for recurrence-free survival (RFS) and OS in younger patients with TNBC.
Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis
TLDR
It was showed that sLeX overexpression is significantly related to lymphatic invasion, venous invasion, T stage, N stage, M stage, tumor stage, recurrence, and overall survival in cancer patients, it plays an important role in cancer prognosis.
ABO Blood Type/Rh Factor and the Incidence and Outcomes for Patients with Triple-Negative Breast Cancer
TLDR
The results failed to demonstrate an association between ABO blood type/Rh factor and breast cancer mortality in patients with TNBC.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer
TLDR
High serum s LeX levels were associated with inflammatory mediators and may play a role in facilitating local invasion of breast tumor and serum MCP-1, IP-10 and sLeX may have prognostic value in breast cancer.
AB0 blood group and prognosis in patients with pancreatic cancer
TLDR
AB0 blood group status is associated independently with the prognosis of patients with resected pancreatic cancer, and favorable and independent impact of blood group 0 on survival is revealed.
Consequences of the expression of sialylated antigens in breast cancer.
TLDR
The aim of this review is to summarize the current knowledge of sialylation changes that occur in breast cancer and to describe the cellular models developed to analyze the consequences of these changes on disease progression and aggressiveness.
Aberrant expression of sLex and sLea as candidate prognostic factors for feline mammary gland tumour
TLDR
The findings suggest that aberrant expression of sLe antigens may be induced by tumourigenesis in FMGT and that sLeAntigens are potential prognostic tumour markers for FMGT.
Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression
TLDR
The results support the use of sLex as a prognostic tumour marker in canine mammary carcinomas and show that sLex and E-Cadherin expression were inversely correlated.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Immunohistochemical expression of ABH/Lewis-related antigens in primary breast carcinomas and metastatic lymph node lesions.
TLDR
Results suggest a possible relationship between the metastatic behavior of the tumor and expression of the blood group antigens in normal and tumor tissues in patients with primary breast carcinoma.
Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma.
TLDR
Sialyl Lewis(a) antigen expression in primary tumors and metastases to regional lymph nodes is a useful marker for evaluating tumor aggressiveness and prognosis in patients with advanced colorectal cancer.
Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer.
TLDR
Increased expression of the sLe(a) antigen may serve as a potent prognostic indicator for recurrence in patients with gastric cancer.
Immunohistochemical Expression of Blood Group Substances and Related Carbohydrate Antigens in Breast Carcinoma
TLDR
Sialyl Le1, defined by a new monoclonal antibody CSLEX1, may be useful as a tumor–associated antigen independent of Lewis blood group type in breast cancer.
Expression of nm23-H1 Gene and Sialyl Lewis X Antigen in Breast Cancer
TLDR
The results suggest that nm23-H1 gene and sLex may be involved in different steps of the metastatic process in human breast cancer, and immunohistochemical detection of the combination of sLex and nm23 -H1 may be a biologic marker of prognostic significance.
Expression of blood group antigens A, B and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients
TLDR
The expression of ABH isoantigens in carcinoma tissue is an important poor prognostic factor in patients with colorectal cancer and needs to be considered in the design of future trials of therapy.
Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome.
TLDR
High expression of dimeric sialyl-Le(x) correlates with venous invasion and poor outcome in gastric carcinoma and was the only independent prognostic factor within the group of patients with tumor stages II and III.
Immunohistochemical studies of blood group‐related antigens in human superficial esophageal carcinomas
TLDR
Interference of alternations in BGA expression that may be associated with oncogenesis is not clear, but immunohistochemical determination of BGA may be a more advantageous marker to predict the patient's clinical course in superficial esophageal carcinoma.
Correlation of prognosis of breast cancer patients and expression of Ley which acts as a cofactor of tumor procoagulant.
TLDR
Multivariate analysis using the Cox's proportional hazards' regression model showed that Ley expression is an independent prognostic factor, following tumor size and lymph node metastasis, and Ley expression on cancer cell surface is higher than tissue factor and HLA-DR.
Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer.
TLDR
The results indicate that up-regulation of sialyl LewisX is associated with hormonal-resistant, aggressive disease, and this prognostic marker may, therefore, have an important role in selecting proper treatment for patients with metastatic prostate cancer.
...
1
2
3
4
5
...